Cutler Group LP Summit Therapeutics Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$2.55 - $5.07 $2,039 - $4,056	800 Added 800.0%	900 $0
Q3 2023 Nov 07, 2023	SELL	$1.54 - $2.42 $154 - $242	-100 Reduced 50.0%	100 $0
Q2 2023 Jul 18, 2023	SELL	$1.32 - $2.81 $1,848 - $3,934	-1,400 Reduced 87.5%	200 $0
Q1 2023 May 01, 2023	SELL	$1.38 - $5.41 $8,141 - $31,919	-5,900 Reduced 78.67%	1,600 $4,000
Q4 2022 Feb 07, 2023	BUY	$0.68 - $5.31 $5,100 - $39,825	7,500 New	7,500 $14,000

138

64.4M

1.06M

1.02M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.04B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.